To evaluate the antimicrobial susceptibility of Gram-negative bacilli that caused hospital-acquired and community-acquired intra-abdominal infections (IAIs) in China between 2012 and 2013, we determined the susceptibilities to 12 antimicrobials and the extended-spectrum ␤-lactamase (ESBL) statuses of 3,540 IAI isolates from seven geographic areas in China in a central laboratory using CLSI broth microdilution and interpretive standards. Most infections were caused by Escherichia coli (46.3%) and Klebsiella pneumoniae (19.7%). Rates of ESBL-producing E. coli (P ‫؍‬ 0.031), K. pneumoniae (P ‫؍‬ 0.017), and Proteus mirabilis (P ‫؍‬ 0.004) were higher in hospital-acquired IAIs than in community-acquired IAIs. Susceptibilities of enterobacteriaceae to ertapenem, amikacin, piperacillin-tazobactam, and imipenem were 71.3% to 100%, 81.3% to 100%, 64.7% to 100%, and 83.1% to 100%, respectively, but imipenem was ineffective against P. mirabilis (<20%). Although most ESBL-positive hospital-acquired isolates were resistant to third-and fourth-generation cephalosporins, the majority were susceptible to cefoxitin (47.9% to 83.9%). Susceptibilities of ESBL-positive isolates to ampicillin-sulbactam (<10%) were low, whereas susceptibilities to ciprofloxacin (0% to 54.6%) and levofloxacin (0% to 63.6%) varied substantially. The prevalences of cephalosporin-susceptible E. coli and K. pneumoniae were higher in the northeastern and southern regions than in the central and eastern regions, reflecting the ESBL-positive rates in these areas, and were lowest in the Jiangsu-Zhejiang (Jiang-Zhe) area where the rates of carbapenem resistance were also highest. Ertapenem, amikacin, piperacillin-tazobactam, and imipenem are the most efficacious antibiotics for treating IAIs in China, especially those caused by E. coli or K. pneumoniae. Resistance to cephalosporins and carbapenems is more common in the Jiang-Zhe area than in other regions in China.
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A ntimicrobial resistance is a global public health problem. Surgical patients have a particularly high risk of infection. Intraabdominal infections (IAIs) are associated with high morbidity and mortality and are a major cause of severe sepsis in intensive care units (1) . In a recent worldwide observational study of complicated IAIs, the overall mortality rate was 10.5%, and extendedspectrum ␤-lactamase (ESBL) producers were the most prevalent drug-resistant microorganisms involved (2) .
For sepsis patients who require immediate empirical therapy, selecting the optimal antimicrobial medication based on the local antibiogram and current resistance patterns is critical to successful treatment outcomes (3) (4) (5) . The molecular structures of carbapenems differ from those of other ␤-lactam antibiotics, such as penicillins and cephalosporins. Carbapenems are the only ␤-lactam antibiotics that are effective for treating severe infections caused by ESBL-producing bacteria (6) . Thus, the development of carbapenem resistance, especially in ESBL-producing bacteria, is of particular clinical relevance (7, 8) .
The Study for Monitoring Antimicrobial Resistance Trends (SMART) is a global surveillance program that monitors the in vitro antimicrobial susceptibility of aerobic and facultative Gramnegative bacilli (GNB) isolated from patients with IAIs. The findings of SMART will provide clinicians with important insight into current trends in the emergence of antibiotic-resistant bacterial strains involved in IAIs.
In our present study, we analyzed IAI isolates collected from patients in 21 hospitals in 16 cities in China during 2012 and 2013 and determined their susceptibilities to a wide range of antimicrobials to evaluate the trends in emerging antimicrobial resistance in different regions of China.
MATERIALS AND METHODS
Clinical isolates. As shown in Fig. 1, a total (9) . Susceptibility interpretations were based on the CLSI M100-S23 clinical breakpoints (10) . We used the ATCC 25922 strain of E. coli, the ATCC 27853 strain of P. aeruginosa, and the ATCC 700603 strain of K. pneumoniae as reference strains in each set of MIC tests for quality control.
Detection of extended-spectrum ␤-lactamase. Phenotypic identification of ESBL-producing strains of E. coli, K. pneumoniae, P. mirabilis, and K. oxytoca was performed according to the CLSI recommendations (9) . We defined ESBL production as a decrease in the MICs for CTX and CAZ of Ͼ8-fold when tested in combination with clavulanic acid relative to the MICs for CTX and CAZ in the absence of clavulanic acid.
Statistical analysis. Data were included in the statistical analysis only when the results for the corresponding quality control isolates were within the accepted range in the CLSI guidelines (9) . We used a chi-square analysis to compare the ESBL status of the community-acquired IAI isolates with that of the hospital-acquired isolates. The level of statistical significance was set at a P value of Ͻ0.05.
RESULTS
The majority of the infections were caused by E. coli (46.3%), K. pneumoniae (19.7%), P. aeruginosa (9.8%), and A. baumannii (6.6%). The prevalences of hospital-acquired ESBL-producing strains were 68.3% for E. coli, 43.8% for K. pneumoniae, 52.5% for Proteus mirabilis (Table 1) , and 36.7% for K. oxytoca, which were significantly higher than those for community-acquired E. coli (P ϭ 0.031), K. pneumoniae (P ϭ 0.017), and P. mirabilis (P ϭ 0.004), with the exception of community-acquired K. oxytoca (P ϭ 0.425).
The sources of the ESBL-producing bacterial strains that were analyzed are listed in Table 2 . The majority of the IAI specimens were collected from gallbladders (33.7%). Most patients with IAIs caused by K. oxytoca had gallbladder infections. The percentage of IAIs caused by P. mirabilis was high compared with most of the other types of IAIs. The percentages of ESBL-producing E. coli and K. oxytoca strains isolated from the gallbladders of patients with hospital-acquired infections were the lowest ( Table 2 ).
The antimicrobial susceptibilities of E. coli, K. pneumoniae, P. mirabilis, and K. oxytoca and those of E. cloacae, P. aeruginosa, and A. baumannii are shown in Table 3 . The ESBL-producing E. coli, K. pneumoniae, P. mirabilis, and K. oxytoca strains were most susceptible to AMK, ETP, IPM, and TZP. For the ESBL-producing strains, susceptibilities to the third-and fourth-generation cephalosporins, FEP, CTX, CAZ, and CRO, were relatively low. Susceptibility rates ranged from 0% to 45.5%, with the exception of the FEP (100%) and CAX (100%) susceptibility rates for community-acquired K. oxytoca and the FEP, CTX, CAZ, and CRO susceptibility rates (100%) for the community-acquired and CAZ (100%) for the hospital-acquired P. mirabilis strains. The FOX susceptibility rates were higher than those for third-and fourthgeneration cephalosporins but lower than those for AMK, ETP, IPM, and TZP. The CIP and LVX susceptibility rates for ESBLproducing E. coli, K. pneumoniae, P. mirabilis, and K. oxytoca ranged from 0% to 63.6%. The E. cloacae isolates were the most susceptible to AMK, IMP, and ETP (71.3% to 97.1%). The P. aeruginosa isolates were highly susceptible to AMK (Ͼ85%) only, whereas the susceptibility rates for all 12 antimicrobials were generally low (Ͻ50%) for A. baumannii (Table 3) . These data collectively indicate that antimicrobial susceptibilities were generally higher in the community-acquired IAIs than in the hospital-acquired IAIs.
To identify geographical differences in ESBL-positive rates and antimicrobial susceptibilities, we compared hospital-acquired and community-acquired isolates from various regions of China. As shown in Fig. 2 , the ESBL-positive rates for hospital-acquired IAIs were generally higher than those for community-acquired IAIs in almost every region, with the exception of K. pneumoniae in the northeastern region. In addition, ESBL rates varied between the regions, especially those for K. pneumoniae. The highest ESBLpositive rate for E. coli occurred in the southwestern region, whereas the highest ESBL-positive rates for K. pneumoniae occurred in the Jiang-Zhe area and the central region.
As shown in Fig. 3 , antimicrobial susceptibilities for E. coli and K. pneumoniae also varied between the geographic regions, with the greatest differences in the susceptibilities to CAZ, CRO, CTX, and FEP occurring between the northeastern region and the central and southwestern regions. This trend was also observed for the other antimicrobials tested. Our analysis of the interregional differences in antimicrobial susceptibility revealed that the prevalences of antimicrobial-resistant E. coli and K. pneumoniae were highest in the Jiang-Zhe area for all of the drugs tested. Furthermore, the ETP and IPM susceptibilities for K. pneumoniae were significantly lower in the Jiang-Zhe area than in the other regions, indicating that the emergence of carbapenem-resistant K. pneumoniae has occurred more rapidly in that area than in the other regions of China (Fig. 4) .
DISCUSSION
Our analysis of IAI isolates collected in China during 2012 and 2013 revealed that more than half of the infections were caused by E. coli (46.3%) and K. pneumoniae (19.7%), which is consistent with the findings of a worldwide observational study of compli- cated IAIs conducted in 2012, which reported that E. coli (42%) and K. pneumoniae (12%) were the major causes of IAIs (2) . The prevalences of hospital-acquired ESBL-producing strains of E. coli, K. pneumoniae, and P. mirabilis were higher than those of the community-acquired isolates, which reflected the higher susceptibilities of community-acquired E. coli, K. pneumoniae, and P. mirabilis to CAX, CRO, CTX, FEP, FOX, SAM, and TZP (Fig. 5) .
The overall prevalence of ESBL-producing strains of E. coli IAI isolates in China was 64.8%, which is similar to previous reports of ESBL-producing E. coli in 2009 (64.9%) (11) but somewhat less than that reported for 2010 to 2011 and 2011 (68.1% and 68.8%, respectively) (12, 13) . The overall prevalence of ESBL-producing strains of K. pneumoniae IAI isolates in China was 39.9%, which is consistent with the ESBL-positive rates reported for K. pneumoniae in 2010 to 2011 and 2011 (39.3% and 38.1%, respectively) (12, 13) .
Comparing gallbladder ESBL-producing IAI strains with those isolated from other organs, the percentage of gallbladder infections caused by K. oxytoca was notably higher (3.3% versus 0.7%).
With the exception of isolates from peritoneal fluid, the percentage of gallbladder infections caused by P. mirabilis was higher than that for the other sites (3.6% versus 2.4%). This trend in P. mirabilis infections might be attributed to the presence of bile acids, which have antimicrobial properties, leading to the selection of bacteria that are less common among infections at other sites. Of the 12 antimicrobials tested, susceptibilities of Enterobacteriaceae to ETP (71.3 to 100%), AMK (81.3 to 100%), TZP (64.7 to 100%), and IMP (83.1 to 100%) were highest, with the exception of the IMP susceptibility of P. mirabilis (Ͻ20%). The CAZ, CRO, CTX, FEP, CIP, LVX, and SAM susceptibilities were lowest for ESBL-producing IAI isolates, whereas susceptibilities to ETP, AMK, TZP, IMP, and FOX were higher, with the susceptibility rate for FOX being lowest among them. These results are in agreement with recommendations that TZP or IMP-cilastatin be used as an empirical monotherapy and that FEP, CAZ, CIP, and LVX be used for combination therapies, with metronidazole for high-risk IAIs. The use of ETP is recommended only for mild and moderate IAIs, due to the reduced susceptibility of P. aeruginosa strains (14) (15) (16) , and FOX might serve as an alternative to ETP (14, 17) . These findings are also consistent with recently published guidelines (18) . For P. aeruginosa, AMK was most effective, whereas susceptibilities to the other antibiotics were Ͻ80%. A. baumannii demonstrated low susceptibilities to all tested antibiotics (10.9% to 47.4%), among which AMK was the most effective (32.6% to 47.4%), indicating that antimicrobial-resistant A. baumannii is a growing problem in China (19) . Our analysis of differences in susceptibilities among E. coli and K. pneumoniae IAI isolates revealed higher susceptibility rates in the northeastern and southern regions of China and showed that the lowest susceptibility rates occurred in central and southwestern China, with susceptibilities to the third-and fourth-generation cephalosporins, CAZ, CRO, CTX, and FEP, being particularly low in E. coli (Fig. 4) . The ESBL-positive rates, especially those for K. pneumoniae, were higher in central and eastern China, particularly in the Jiang-Zhe area, than in the other regions. The susceptibilities of K. pneumoniae to all of the antibiotics tested, including carbapenems, were lower in the Jiang-Zhe area than in the other regions (Fig. 5) . The Jiang-Zhe area is the most highly developed region in China. Therefore, it is possible that higher incomes and more widely available medical care may have contributed to the overuse of antimicrobials in the region (20, 21) .
The emergence of localized carbapenem-resistant Enterobacteriaceae has been reported for Verona integron-encoded metallo-␤-lactamase-producing bacterial strains in Greece (22) and for carbapenemase-producing K. pneumoniae in the United States (23) . A recent study showed that carbapenem-resistant K. pneumoniae strains were more prevalent in the northeastern region of the United States than in the Midwest, suggesting that antimicrobial-resistant bacteria had spread west following initial outbreaks in New York City between 2000 and 2005 (24) . Our findings suggest that an outbreak of carbapenem-resistant K. pneumoniae may have occurred at a single medical center in the Jiang-Zhe area, which subsequently spread into the surrounding regions.
In conclusion, our findings showed that both hospital-acquired and community-acquired E. coli, K. pneumoniae, P. mirabilis, and K. oxytoca IAI isolates in China were most susceptible to ETP, AMK, TZP, and IPM. We also found that the prevalence of hospital-acquired ESBL-positive IAI isolates was higher than that of community-acquired IAI isolates, which reflected the low susceptibilities of hospital-acquired isolates to third-and fourth-generation cephalosporins. Antimicrobial susceptibilities of Enterobacteriaceae were higher in the northwestern and southern regions of China than in the central and eastern regions. The K. pneumoniae IAI isolates from the Jiang-Zhe area exhibited higher levels of resistance to all 12 of the antimicrobials tested than the bacterial isolates from other regions in China.
